Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
出版年份 2021 全文链接
标题
Cell-Associated HIV-1 Unspliced-to-Multiply-Spliced RNA Ratio at 12 Weeks of ART Predicts Immune Reconstitution on Therapy
作者
关键词
-
出版物
mBio
Volume 12, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2021-03-08
DOI
10.1128/mbio.00099-21
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Filgotinib suppresses HIV-1–driven gene transcription by inhibiting HIV-1 splicing and T cell activation
- (2020) Yang-Hui Jimmy Yeh et al. JOURNAL OF CLINICAL INVESTIGATION
- Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion
- (2019) Marilia Rita Pinzone et al. Nature Communications
- Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance
- (2019) Serena Spudich et al. JOURNAL OF CLINICAL INVESTIGATION
- Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study
- (2019) Veronica Bordoni et al. PLoS One
- Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs
- (2018) Maria C Puertas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV latency in isolated patient CD4 + T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing
- (2018) Steven A. Yukl et al. Science Translational Medicine
- CD4 cell count recovery after combined antiretroviral therapy in the modern cART era
- (2018) Hélène Roul et al. AIDS
- Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion
- (2017) OT Stirrup et al. HIV MEDICINE
- Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus–Infected Individuals Receiving Suppressive Antiretroviral Therapy
- (2017) Gabriela Khoury et al. JOURNAL OF INFECTIOUS DISEASES
- Re-evaluating evolution in the HIV reservoir
- (2017) Daniel I. S. Rosenbloom et al. NATURE
- Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
- (2017) Rajesh T. Gandhi et al. PLoS Pathogens
- T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment
- (2016) Viviana Cobos Jiménez et al. JOURNAL OF INFECTIOUS DISEASES
- Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy
- (2016) Aya Ishizaka et al. JOURNAL OF VIROLOGY
- Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells
- (2016) Benoît Lacombe et al. JOURNAL OF VIROLOGY
- International AIDS Society global scientific strategy: towards an HIV cure 2016
- (2016) Steven G Deeks et al. NATURE MEDICINE
- Residual inflammation and viral reservoirs
- (2016) Marta Massanella et al. Current Opinion in HIV and AIDS
- Cell-Associated HIV-1 DNA and RNA Decay Dynamics During Early Combination Antiretroviral Therapy in HIV-1-Infected Infants
- (2015) Priyanka Uprety et al. CLINICAL INFECTIOUS DISEASES
- Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients
- (2015) Wei Zhen Chow et al. PLoS One
- Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease
- (2014) Leslie R. Cockerham et al. AIDS
- Regulatory T Cells in HIV-Infected Immunological Nonresponders Are Increased in Blood but Depleted in Lymphoid Tissue and Predict Immunological Reconstitution
- (2014) Julie C. Gaardbo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Kynurenine Pathway of Tryptophan Catabolism, CD4+ T-Cell Recovery, and Mortality Among HIV-Infected Ugandans Initiating Antiretroviral Therapy
- (2014) H. Byakwaga et al. JOURNAL OF INFECTIOUS DISEASES
- Higher CD27+CD8+ T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4+ T Cell Recovery in Treated HIV Infection
- (2014) Lillian Seu et al. PLoS One
- CD4+ and CD8+ T Cell Activation Are Associated with HIV DNA in Resting CD4+ T Cells
- (2014) Leslie R. Cockerham et al. PLoS One
- Immune activation and HIV persistence: implications for curative approaches to HIV infection
- (2013) Nichole R. Klatt et al. IMMUNOLOGICAL REVIEWS
- Antiretroviral Therapy Initiated During Acute HIV Infection Fails to Prevent Persistent T-Cell Activation
- (2013) Michael J. Vinikoor et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Programmed Death-1 Is a Marker for Abnormal Distribution of Naive/Memory T Cell Subsets in HIV-1 Infection
- (2013) G. Breton et al. JOURNAL OF IMMUNOLOGY
- Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine
- (2013) Nicholas T. Funderburg et al. PLoS One
- Immune activation and HIV persistence
- (2013) Hiroyu Hatano Current Opinion in HIV and AIDS
- HIV Latency
- (2013) R. F. Siliciano et al. Cold Spring Harbor Perspectives in Medicine
- Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery
- (2012) Marta Massanella et al. AIDS
- The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients
- (2012) Alejandro Vallejo et al. AIDS
- Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment
- (2012) Giuseppe Lapadula et al. AIDS
- An Analog of the Natural Steroidal Alkaloid Cortistatin A Potently Suppresses Tat-Dependent HIV Transcription
- (2012) Guillaume Mousseau et al. Cell Host & Microbe
- HIV RNA Suppression and Immune Restoration: Can We Do Better?
- (2012) Marilia Rita Pinzone et al. Clinical & Developmental Immunology
- Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions
- (2012) Julie C. Gaardbo et al. Clinical & Developmental Immunology
- Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration
- (2012) G. Mendez-Lagares et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Modest Nonadherence to Antiretroviral Therapy Promotes Residual HIV-1 Replication in the Absence of Virological Rebound in Plasma
- (2012) Alexander O. Pasternak et al. JOURNAL OF INFECTIOUS DISEASES
- Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)–Expressing CD4+ T cells
- (2012) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Factors Predicting Discordant Virological and Immunological Responses to Antiretroviral Therapy in HIV-1 Clade C Infected Zulu/Xhosa in South Africa
- (2012) Boris Julg et al. PLoS One
- Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
- (2011) Peter W. Hunt et al. AIDS
- Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort
- (2011) Steven F.L. van Lelyveld et al. AIDS
- Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week study
- (2011) Josep M Llibre et al. ANTIVIRAL THERAPY
- Immune reconstitution under antiretroviral therapy: the new challenge in HIV-1 infection
- (2011) P. Corbeau et al. BLOOD
- Reduced Thymic Output Is a Major Mechanism of Immune Reconstitution Failure in HIV-Infected Patients After Long-term Antiretroviral Therapy
- (2011) Taisheng Li et al. CLINICAL INFECTIOUS DISEASES
- HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS
- (2011) Gabriella d'Ettorre et al. CURRENT HIV RESEARCH
- A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
- (2011) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- CD4+ T-Cell Deficiency in HIV Patients Responding to Antiretroviral Therapy Is Associated With Increased Expression of Interferon-Stimulated Genes in CD4+ T Cells
- (2011) Sonia Fernandez et al. JOURNAL OF INFECTIOUS DISEASES
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
- (2011) Michael M. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection
- (2010) Judith J Lok et al. AIDS
- Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy
- (2010) Stefania Piconi et al. AIDS
- Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy
- (2010) Steven A Yukl et al. AIDS
- CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART
- (2010) Marta Massanella et al. AIDS
- Measurement of Naive CD4 Cells Reliably Predicts Potential for Immune Reconstitution in HIV
- (2010) Timothy W Schacker et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection
- (2010) Adrian Schmid et al. PLoS One
- Residual Viraemia in HIV-1-Infected Patients with Plasma Viral Load ≤20 copies/ml is Associated with Increased Blood Levels of Soluble Immune Activation Markers
- (2010) S. R. Ostrowski et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral Treatment
- (2009) Colleen F. Kelley et al. CLINICAL INFECTIOUS DISEASES
- Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD)
- (2009) Sam Egger et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
- (2009) S. Molina-Pinelo et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Plasma Levels of Bacterial DNA Correlate with Immune Activation and the Magnitude of Immune Restoration in Persons with Antiretroviral‐Treated HIV Infection
- (2009) Wei Jiang et al. JOURNAL OF INFECTIOUS DISEASES
- HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation
- (2009) Nicolas Chomont et al. NATURE MEDICINE
- Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome
- (2009) Alexander O. Pasternak et al. PLoS One
- HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
- (2009) Maud Mavigner et al. PLoS One
- CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
- (2008) Jason V Baker et al. AIDS
- Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets
- (2008) S. Kohler et al. BLOOD
- CD4+T Cell Count Recovery in HIV Type 1–Infected Patients Is Independent of Class of Antiretroviral Therapy
- (2008) Nina Khanna et al. CLINICAL INFECTIOUS DISEASES
- Highly Sensitive Methods Based on Seminested Real-Time Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 Unspliced and Multiply Spliced RNA and Proviral DNA
- (2008) A. O. Pasternak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
- (2008) S. Palmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started